InsidersTradesSigma
Browse the detailed record of transactions filed by BILINSKY IGOR, Chief Operating Officer. Officer active across 1 companies, notably Iovance Biotherapeutics, INC.. Cumulatively, 1 reports have been logged. The latest transaction was disclosed on 14 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Igor Bilinsky is the Chief Operating Officer at IOVANCE BIOTHERAPEUTICS, INC. He oversees the daily operations of the company and is responsible for optimizing processes to enhance efficiency and profitability. With a strong background in operational management, Igor plays a key role in implementing the company's strategy and developing new initiatives to support growth.